Brent Ragans – President, Ferring Pharmaceuticals US

Brent Ragans of Ferring Pharmaceuticals US discusses the effects of the COVID-19 pandemic on the company’s operations, their footprint in reproductive health and Crohn’s Disease, virtual product launches and digitalisation, and the battle for talent in the competitive US market.  
US physicians have learned that, out of necessity, they have to triage patients through digital tools like teleconferencing and Zoom, which has enabled them to become more efficient and see more patients
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In

Related Interviews

Latest Report